| Jul 8 |
Amarin partner EddingPharm receives approval for VASCEPA in China
|
| Jul 8 |
Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR)
|
| Jun 4 |
Sector Update: Health Care Stocks Rise Tuesday Afternoon
|
| Jun 4 |
Amarin falls on CEO exit and Vascepa coverage update
|
| Jun 4 |
Amarin names Aaron Berg as CEO
|
| Jun 4 |
Amarin Board of Directors Announces CEO Transition
|
| May 28 |
Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A.
|
